Position
Chief Scientific Officer
Company
Stoke Therapeutics, Inc.
Description
Stoke Therapeutics, Inc. announced the appointment of Thomas McCauley, Ph.D., as Chief Scientific Officer. Dr
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Tarsus Pharmaceuticals Appoints Neera Clase as Interim Chief Commercial Officer (July 13, 2026)
- Ovid Therapeutics Inc. Appoints Kevin Norrett as Chief Business Officer and Promotes Charles Carter to CFO (July 14, 2026)
- Illuminare Biotechnologies Appoints Brian Longstreet as Chief Executive Officer (July 14, 2026)
- EyePoint Appoints Tarek S. Hassan as Senior Vice President, Chief Strategic Science Officer (July 14, 2026)
- BioCryst Pharmaceuticals Appoints David W. Jenkins as Chief Scientific Officer (July 15, 2026)
- Biohaven Ltd. Appoints David Pirman as Executive Vice President and Head of Discovery (July 9, 2026)
Who to call at Stoke Therapeutics, Inc., and when
A new leader at Stoke Therapeutics, Inc. brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Stoke Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Stoke Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Stoke Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Stoke Therapeutics, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Stoke Therapeutics, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.